• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Influence of lactulose on interventional therapy for HCC patients with hepatocirrhosis and hypersplenism

    2016-11-29 12:06:07DengWeiZongChenYangGuoHongTaoChengHongTaoHuJinChengXiaoHaiLiangLi

    Deng-Wei Zong, Chen-Yang Guo, Hong-Tao Cheng, Hong-Tao Hu, Jin-Cheng Xiao, Hai-Liang Li

    Department of Radiology Intervention, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China

    Influence of lactulose on interventional therapy for HCC patients with hepatocirrhosis and hypersplenism

    Deng-Wei Zong, Chen-Yang Guo, Hong-Tao Cheng, Hong-Tao Hu, Jin-Cheng Xiao, Hai-Liang Li*

    Department of Radiology Intervention, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China

    ARTICLE INFO

    Article history:

    Received 15 November 2015

    Received in revised form 20 December 2015

    Accepted 15 January 2016

    Available online 20 February 2016

    Lactulose

    Interventional therapy

    Immunity

    Hepatocellular carcinoma

    Hepatocirrhosis

    Hypersplenism

    Objective: To investigate the influence of lactulose on immunity of hepatocellular carcinoma (HCC) patients with hepatocirrhosis and hypersplenism after double-interventional therapies. Methods: A total of 40 HCC patients with hepatocirrhosis and hypersplenism, hospitalized during January 2013 to June 2014, were enrolled and randomized into control group and observation group. Both groups received partial splenic embolization combined with transcatheter arterial chemoembolization. Besides, observation group orally took lactulose 30 mL/d. Four days before interventional therapies and at day 1, 3, 7 and 14 after therapies, fasting venous blood was collected to detect white blood cell count, red blood cell count (RBC), and platelet count (PLT). Four days before therapies and at day 7 and 14 after therapies, the levels of alanine aminotransferase, aspartate transaminase, total bilirubin, malondialdehyde, super-oxide dismutase (SOD), IFN-γ, and IL-4 as well as the distribution of T cell subsets in peripheral blood were tested. Complications were observed after interventional therapies. Results: Before interventional therapies the levels of white blood cell count, PLT and RBC in both groups showed no difference, while after interventional therapies the levels of PLT and RBC in both groups showed an increasing tendency (P<0.05). At day 14 after interventional therapies, the level of blood cell as well as that of SOD, IFN-γ and IL-4 in serum were significantly higher than that before therapies; meanwhile, the levels of alanine aminotransferase and total bilirubin of observation group after therapies were significantly lower than before and control group (P<0.05), the levels of CD4+/CD8+, SOD and IFN-γ were all higher than before and control group (P<0.05). Conclusions: Oral administration of lactulose could adjust the imbalance of oxidation system/antioxidant system in HCC patients with hepatocirrhosis and hypersplenism after interventional therapies, and improve the antitumor immunity and prognosis.

    1. Introduction

    Hepatocellular carcinoma (HCC) is one of the most common types of malignant liver cancer with high morbidity and mortality. In the past decades, the global morbidity of HCC has been on a sharp upward trend; the morbidity of HCC in United States is even twiceas much as the average level of the world[1]. As most patients are already at the advanced stage when HCC is diagnosed, the tumors are often inoperable. Therefore, palliative therapy is the principle therapeutic method of HCC. Among all the palliative therapies, transcatheter arterial chemoembolization (TACE) is most frequently adopted. It can significantly increase survival of HCC patients with unresectable tumors[2-4]. It’s reported that about 80% of HCC patients have hepatocirrhosis, because HCC mostly develops from hepatocirrhosis or liver fibrosis. In addition, hepatocirrhosis usually also causes portal hypertension and hypersplenism. Recent studies have shown that partial splenic embolization (PSE) can permanently improve thrombocytopenia and hypersplenism caused by portal hypertension[5].

    As an oral disaccharide, lactulose can promote nitrogen balance and excretion; therefore, it is widely used in the treatment of hepatic encephalopathy and constipation[6,7]. The pharmacokinetic characteristics of lactulose make it an effective and safe option for the treatment of such indications. However, many of its potential effects are still unknown. In this study, HCC patients with hepatocirrhosis and hypersplenism received lactulose orally, to investigate the influence of lactulose on the efficacy of interventional therapy and antioxidant system, thus providing theoretical basis for the comprehensive treatment of the disease.

    2. Materials and methods

    2.1. General data

    A total 40 HCC patients with hepatocirrhosis and hypersplenism, hospitalized during January 2013 to June 2014, were chosen as subjects. The diagnosis of HCC fits in with relevant guidelines[8], and the diagnosis of hypersplenism should fit in with the following criterias: type-B ultrasound or CT scan shows hepatocirrhosis, spleen pachydiameter>4.1 cm, classⅠ splenomegaly, white blood cell count (WBC)<3×109/L, and platelet count (PLT)<100×109/ L[9]. The liver condition of all patients was either Child-Pugh A or Child-Pugh B. No patient had taken immunomodulator within 30 d before the treatment.

    The patients were randomly divided into control group and observation group, with 20 patients in each group. Double intervention with TACE and PSE began after no patient was found contraindications.

    2.2. Therapeutic methods

    In case there might be ascites, sufficient support therapy was given to all patients before the intervention. During the procedure, all patients fitting in with the inclusion criterias received PSE first, and then TACE. PSE procedures: The catheter was inserted into the femoral artery via Seldinger method, following with abdominal angiogram and selective splenic arteriography to observe the distribution of splenic artery and routes of collateral circulation. Then, the tip of the catheter was placed at the splenic hilum and the gelatin sponge was suspended in the contrast media to form embolization; the scope of splenic embolization was assessed by angiogram. When a 40%~60% ablation of the splenic parenchyma was obtained, the embolization was terminated. After the PSE procedure, TACE was performed under aseptic condition: the catheter was inserted into the femoral artery as in the PSE procedure, following with abdominal angiogram and selective splenic arteriography to observe tumor blood-supply, the distribution of hepatic artery and routes of collateral circulation. The tip of the catheter was placed at the feeding artery of the tumor and embolization was performed using an emulsion mixture of lipoidal ultra-fluid, perarubicin and DDP (the dose of embolization depends on tumor size, blood supply and hepatic function of the patient). When the tumor was filled well with emulsifier, the embolization was terminated.

    In addition, from day 3 before the interventional therapies to day 14 after therapies, the observation group took lactulose orally; the control group took placebo. For the observation group, lactulose syrup was administered as 30 mL/d in divided doses for a stool frequency of two to three soft defecations per day.

    2.3. Observation items

    Clinical symptoms and complications were observed after the interventional therapies. Four days before interventional therapies and at day 1, 3, 7 and 14 after them, fasting venous blood was collected to detect WBC, red blood cell count (RBC), and PLT. Four days before interventional therapies and at day 7 and 14 after them, levels of alanine aminotransferase (ALT), aspartate transaminase (AST) and total bilirubin (TBil) were tested; meanwhile, peripheral venous blood was collected for measuring levels of CD4+T cell and CD8+T cells by flow cytometry, in order to obtain the ratio of CD4+/ CD8+.

    Four days before interventional therapies and at day 7 and 14 after them, fasting blood sample was collected; thiobarbituric acid chromatometry was used to assay the content of malondialdehyde (MDA) in blood, xanthinoxidase method was used to assay the content of super-oxide dismutase (SOD), and ELISA was used to detect the levels of IFN-γ and IL-4 in serum. All reagent kits were bought from Shijiazhuang Huarui Biotech R&D Center.

    2.4. Data Statistics

    SPSS l6.0 software was used for statistical analysis and all the data was represented by mean±SD. The paired t-test was used to compare the indexes of the same group before and after the procedure; the independent t-test was used to compare the indexes of two groups; enumeration data was compared by χ2test. When P<0.05, the differences were considered statistically significant.

    3. Results

    3.1. Levels of peripheral blood cell and transaminase after interventional therapies

    After interventional therapies, WBC content and PLT content of both groups showed significant increase compared with the preoperative content (P<0.05); at day 14 after interventional therapies, levels of ALT and TBil of the observation group patients were higher than preoperative levels and those of control group (P<0.05); concerning the RBC and AST level, the post-treatment level in both groups showed no significant difference compared with the preoperative level (Table 1).

    Table 1Blood cells and aminotransferase contents at different time points.

    After the therapies, both groups showed a slowly rising trend on the percentage of CD4+T cell, but a slowly decreasing trend on the percentage of CD8+T cell; at day 14 after the therapies, the ration of CD4+/CD8+in the observation group was significantly higher than that before therapies (P<0.05).

    3.2. Levels of SOD, MDA, IFN-γ and IL-4 before and after interventional therapies

    According to Table 2, at day 14 after interventional therapies, levels of SOD, IFN-γ and IL-4 in both groups increased significantly, while the observation group showed higher levels of SOD and IFN-γ than the control group (P<0.05). At day 14 after therapies, MDA content of the observation group was significantly lower than that before therapies (P<0.05); however, there was no significant change in MDA content of the control group (P>0.05).

    Table 2Levels of serum antioxidants and cytokines at different time points before and after interventional therapies.

    3.3. Incidence of complications after interventional therapies

    After interventional therapies, patients of both groups suffered pain, fever, nausea and vomiting, and left subdiaphragmatic effusion. However, in generally, two groups showed no difference in complications incidence (P>0.05).

    4. Discussion

    In clinic, lactulose is mainly used in the treatment of constipation and hepatic encephalopathy. In fact, its effects are far more than that. It can also reduce endotoxin, affect trace element metabolism, regulate intestinal flora balance, affect the circulation of bile acid, resist oxidation, and strengthen immunity and so on. In the study, all patients received double-interventional therapies. Moreover, lactulose was given to patients of observation group to observe the influence of lactulose on therapeutic effect. Our results showed that the observation group and the control group showed no difference in the levels of blood cell and transaminase after the therapies and also in the postoperative complications incidence. However, levels of antioxidant enzyme and cytokines were more significantly improved in patients having taken lactulose than in those having not (P<0.05).

    Hepatocirrhosis is the advanced stage of chronic liver disease, which is a result of various repeated or long-term damages to the liver. In China, hepatocirrhosis is mainly caused by viral hepatitis and develops from liver fibrosis[10]. Although hepatocirrhosis is the result of many factors, the role of oxidative stress should not be ignored, which influences the development of hepatocirrhosis from various aspects[11,12]. It has been verified that the reactive oxygen species (ROS) can induce lipid peroxidation leading to inflammation and fibrogenesis through the activation of stellate cells[13]. In addition, ROS is the critical mediator of liver firbrosis, and it also contributes to hepatic fibrosis from various kinds of liver injuries[12,14]. SOD is an antioxidant enzyme that constitutes the first line of defence against ROS. It reflects the body’s ability and degree of reducing free radical. MDA represents the change of ROS content and the degree of lipid peroxidation and indirectly reflects the degree of ROS’s damage to tissues. Joint detection of MDA and SOD can indicate the body’s condition of oxidation and peroxidation.

    This study found that lactulose can significantly improve patients’postoperative level of SOD and meanwhile inhibit MDA content, which indicated that lactulose can improve the curative effect of interventional therapy by reducing oxidative stress. Yu et al[15] investigated the potential influence of lactulose administration on liver regeneration, and they concluded that lactulose administration accelerates posthepatectomized liver regeneration in rats by inducing hydrogen, which may result from attenuation of the oxidative stress response and excessive inflammatory response. In the mouse model of human ulcerative colitis, Chen et al[16] foundthat lactulose can prevent the development of DSS-induced colitis and alleviate oxidative stress in the colon, probably by increasing endogenous H2production. In a word, lactulose can eliminate free radicals, adjust the imbalance between oxidation system and antioxidant system, and alleviate liver injury.

    Cellular immunity often plays an important role in tumor immunity. When the body has strong antitumor immunity, there is mainly the secretion of Th1 cytokines; while there is mainly the secretion of Th2 cytokines, the body’s antitumor immunity is inhibited. IFN-γ and IL-4 are representative cytokines respectively produced by Th1 cells and Th2 cells. The study showed that at day 14 after interventional therapies, the level of IFN-γ in observation group was significantly higher than that in control group, while the two groups showed no difference in the level of IL-4, which suggested that Th1/Th2 cell polarization evidently shifted to Th1 cells, and patients’ antitumor immunity was significantly enhanced after the administration of lactulose. Vendemiale et al[17] also found the effect of activation on cell-mediated immune system depressed during liver cirrhosis, produced by lactulose. There are many other studies having confirmed the positive role of lactulose on the immune defense and immune regulation[18,19]. However, further studies are still needed to confirm and clarify the possible mechanisms involved.

    In summary, oral adminstration of lactulose could adjust the imbalance between the oxidation system and the antioxidant system of HCC patients with hepatocirrhosis and hypersplenism after interventional therapies, alleviate liver injury, improve the antitumor immunity and prognosis.

    Conflict of interest statement

    We declare that we have no conflict of interest.

    [1] El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004; 127(5 Suppl 1): S27-S34.

    [2] Lesmana LA, Gani RA, Hasan I, Waspodo A, Boedi P, Luwia MS, et al. Influence of the sorafenib patients assistance program on treatment compliance and overall survival of unresectable hepatocellular carcinoma patients. Acta Med Indones 2012; 44(3): 228-232.

    [3] Heinzow HS, Brockmann JG, K?hler M, Wolters HH, Senninger N, Schmidt H, et al. Liver transplantation versus supraselective transarterial chemoembolization in palliative patients with hepatocellular carcinoma exceeding the Milan Criteria- is it time for a more individual approach? Ann Transplant 2013; 18: 515-524.

    [4] Koike Y, Takizawa K, Ogawa Y, Muto A, Yoshimatsu M, Yagihashi K, et al. Transcatheter arterial chemoembolization (TACE) or embolization (TAE) for symptomatic bone metastases as a palliative treatment. Cardiovasc Intervent Radiol 2011; 34(4): 793-801.

    [5] Helaly AZ, Al-Warraky MS, El-Azab GI, Kohla MA, Abdelaal EE. Portal and splanchnic hemodynamics after partial splenic embolization in cirrhotic patients with hypersplenism. APMIS 2015; 123(12): 1032-1039.

    [6] Jiang SM, Jia L, Zhang MH. Probiotic and lactulose: influence on gastrointestinal flora and pH value in minimal hepatic encephalopathy rats. Int J Clin Exp Med 2015; 8(6): 9996-10000.

    [7] Treepongkaruna S, Simakachorn N, Pienvichit P, Varavithya W, Tongpenyai Y, Garnier P, et al. A randomized, double-blind study of polyethylene glycol 4000 and lactulose in the treatment of constipation in children. BMC Pediatr 2014; 14: 153.

    [8] Chinese Society of Liver Cancer. Diagnostic criteria for hepatocellular carcinoma. Chin J Hepatol 2000; 8(3): 135.

    [9] Chen XP, Wu ZD, Qiu FZ. Role of united hepatectomy and splenectomy in the surgical treatment of hepatocellular carcinoma complicated with hepatic cirrhosis and hypersplenism. Zhonghua Wai Ke Za Zhi 2005; 43(7): 442-446.

    [10] Jia D, Duan F, Peng P, Sun L, Ruan Y, Gu J. Pyrroloquinoline-quinone surrresses liver fibrogenesis in mice. PLoS One 2015; 10(3): e0121939.

    [11] Esrefoglu M. Oxidative stress and benefits of antioxidants agents in acute and chronic hepatitis. Hepat Mon 2012; 12(3): 160-167.

    [12] Lucchesi AN, Freitas NT, Cassettari LL, Marques SF, Spadella CT. Diabetes mellitus triggers oxidative stress in the liver of alloxan-treated rats: a mechanism for diabetic chronic liver disease. Acta Cir Bras 2013; 28(7): 502-508.

    [13] Borkham-Kamphorst E, Schaffrath C, Van de Leur E, Haas U, Tihaa L, Meurer SK, et al. The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated TGF-β signaling. Biochim Biophys Acta 2014; 1843(5): 902-914.

    [14] Kleme ML, Levy E. Cystic fibrosis-related oxidative stress and intestinal disorders. Antioxid Redox Signal 2015; 22(7): 614-631.

    [15] Yu J, Zhang W, Zhang R, Ruan X, Ren P, Lu B. Lactulose accelerates liver regeneration in rats by inducing hydrogen. J Surg Res 2015; 195(1): 128-135.

    [16] Chen X, Zhai X, Shi J, Liu WW, Tao H, Sun X, et al. Lactulose mediates suppression of dextran sodium sulfate-induced inflammation by increasing hydrogen production. Dig Dis Sci 2013; 58(6): 1560-1568.

    [17] Vendemiale G, Palasciano G, Cirelli F, Altamura M, De Vincentiis A, Altomare E. Crystalline lactulose in the therapy of hepatic cirrhosis. Evaluation of clinical and immunological parameters. Preliminary results. Arzneimittelforschung 1992; 42(7): 969-972.

    [18] Dehghan MH, Gupta VR, Asif SM, Darwis Y, Rizwan M, Mundada VP. Assessment of isomalt for colon-specific delivery and its comparison with lactulose. AAPS Pharm Sci Tech 2013; 14(1): 53-59.

    [19] Masanetz S, Prei?inger W, Meyer HH, Pfaffl MW. Effects of the prebiotics inulin and lactulose on intestinal immunology and hematology of preruminant calves. Animal 2011; 5(7): 1099-1106.

    ent heading

    10.1016/j.apjtm.2016.01.011

    *Corresponding author: Hai-Liang Li, Department of Radiology Intervention, Affiliated Cancer Hospital of Zhengzhou University, No.127 Dongming Road, Zhengzhou, China.

    Tel: 13903861969

    E-mail: cjr.lihailiang@vip.163.com

    Foundation project: This research is supported by the Key Scientific and Technological Project of Henan Province (08210231002).

    午夜激情av网站| 中文字幕人妻熟人妻熟丝袜美| videos熟女内射| 国产精品一区二区三区四区免费观看| av在线观看视频网站免费| a级毛色黄片| a 毛片基地| 97在线人人人人妻| 日韩亚洲欧美综合| 中文字幕免费在线视频6| a级片在线免费高清观看视频| 男女免费视频国产| 国产亚洲欧美精品永久| 一本一本综合久久| 少妇精品久久久久久久| 狠狠婷婷综合久久久久久88av| 又大又黄又爽视频免费| 亚洲婷婷狠狠爱综合网| 国产深夜福利视频在线观看| 精品国产一区二区三区久久久樱花| 91aial.com中文字幕在线观看| 97在线视频观看| 老司机影院成人| 免费黄频网站在线观看国产| 99视频精品全部免费 在线| 99热国产这里只有精品6| 校园人妻丝袜中文字幕| 午夜精品国产一区二区电影| 国产免费现黄频在线看| 人人妻人人澡人人看| 国产黄片视频在线免费观看| 欧美 日韩 精品 国产| 色5月婷婷丁香| 最新的欧美精品一区二区| 国产亚洲午夜精品一区二区久久| 麻豆乱淫一区二区| 欧美激情 高清一区二区三区| 美女大奶头黄色视频| 国产国语露脸激情在线看| 亚洲情色 制服丝袜| 久久人人爽人人片av| 亚洲怡红院男人天堂| 人人澡人人妻人| 狂野欧美白嫩少妇大欣赏| 日韩一区二区视频免费看| 纵有疾风起免费观看全集完整版| 日本猛色少妇xxxxx猛交久久| 一本一本综合久久| 久久久欧美国产精品| 一级,二级,三级黄色视频| 精品久久久久久久久av| 麻豆乱淫一区二区| 欧美+日韩+精品| 国产精品偷伦视频观看了| 伦理电影免费视频| 飞空精品影院首页| 国产av精品麻豆| 国产成人免费观看mmmm| 亚洲国产最新在线播放| 精品一区二区三卡| 只有这里有精品99| 卡戴珊不雅视频在线播放| 特大巨黑吊av在线直播| 九草在线视频观看| 久久精品国产自在天天线| 亚洲欧美日韩卡通动漫| 久久精品国产鲁丝片午夜精品| videosex国产| 亚洲精品色激情综合| 欧美 亚洲 国产 日韩一| 免费黄频网站在线观看国产| 精品人妻偷拍中文字幕| 欧美日韩视频高清一区二区三区二| 欧美3d第一页| 免费大片黄手机在线观看| 欧美人与性动交α欧美精品济南到 | 丝瓜视频免费看黄片| 久久久久久久久久久免费av| 久久久久视频综合| 午夜激情福利司机影院| 97超碰精品成人国产| 久久99精品国语久久久| 国产综合精华液| 亚洲国产欧美日韩在线播放| 最近中文字幕2019免费版| 久久久久久伊人网av| 国产精品久久久久成人av| 国产一区有黄有色的免费视频| 高清黄色对白视频在线免费看| 高清av免费在线| 久久久久网色| 日韩成人伦理影院| 日韩精品有码人妻一区| 亚洲婷婷狠狠爱综合网| 美女中出高潮动态图| 22中文网久久字幕| 国产精品一区二区在线不卡| 欧美丝袜亚洲另类| 国产白丝娇喘喷水9色精品| 国产一区二区在线观看av| 精品久久久精品久久久| 人妻 亚洲 视频| 亚洲av中文av极速乱| 9色porny在线观看| 十八禁高潮呻吟视频| 肉色欧美久久久久久久蜜桃| 免费av中文字幕在线| 久久久久国产精品人妻一区二区| 一个人看视频在线观看www免费| 少妇丰满av| 99九九在线精品视频| 在线观看一区二区三区激情| 91国产中文字幕| 啦啦啦中文免费视频观看日本| 久久久久久人妻| 99精国产麻豆久久婷婷| 男女边吃奶边做爰视频| 天堂俺去俺来也www色官网| 久久鲁丝午夜福利片| 搡女人真爽免费视频火全软件| 午夜91福利影院| 亚洲国产毛片av蜜桃av| 天天躁夜夜躁狠狠久久av| 制服人妻中文乱码| 女的被弄到高潮叫床怎么办| 久久女婷五月综合色啪小说| 97在线视频观看| 妹子高潮喷水视频| 精品国产露脸久久av麻豆| 久久久国产一区二区| 亚洲五月色婷婷综合| 亚洲,欧美,日韩| 日韩伦理黄色片| 亚洲欧美清纯卡通| 日韩成人伦理影院| 内地一区二区视频在线| 亚洲欧美一区二区三区黑人 | 亚洲伊人久久精品综合| 在现免费观看毛片| 久久久久久久久久成人| 成人国语在线视频| 欧美3d第一页| 久久国产精品大桥未久av| 又粗又硬又长又爽又黄的视频| 狂野欧美激情性bbbbbb| 成人亚洲精品一区在线观看| 国产男人的电影天堂91| 欧美日韩亚洲高清精品| 熟女电影av网| 18禁在线播放成人免费| 国产精品麻豆人妻色哟哟久久| 国产永久视频网站| 久久综合国产亚洲精品| av线在线观看网站| 91久久精品电影网| 中文字幕av电影在线播放| 久久久a久久爽久久v久久| 精品人妻偷拍中文字幕| videossex国产| 男人添女人高潮全过程视频| 久久精品久久久久久噜噜老黄| 99久久精品国产国产毛片| 赤兔流量卡办理| 精品久久久久久久久亚洲| 丰满少妇做爰视频| 高清视频免费观看一区二区| av免费在线看不卡| 韩国高清视频一区二区三区| 亚洲国产精品一区二区三区在线| 国产精品女同一区二区软件| 免费少妇av软件| 亚洲精品,欧美精品| 丝袜美足系列| 国产精品不卡视频一区二区| 99久久中文字幕三级久久日本| 曰老女人黄片| 女人久久www免费人成看片| 97超视频在线观看视频| 久热久热在线精品观看| 亚洲av欧美aⅴ国产| 日本爱情动作片www.在线观看| 日本91视频免费播放| 亚洲av国产av综合av卡| 久久国内精品自在自线图片| 成人午夜精彩视频在线观看| 亚洲一区二区三区欧美精品| 一区二区三区免费毛片| 成人综合一区亚洲| 在线看a的网站| 18禁在线播放成人免费| 成人综合一区亚洲| 九九久久精品国产亚洲av麻豆| 丝袜脚勾引网站| 免费大片黄手机在线观看| 欧美精品国产亚洲| av线在线观看网站| 亚洲精品乱码久久久久久按摩| 亚洲精品av麻豆狂野| 亚洲第一av免费看| 日韩不卡一区二区三区视频在线| 亚洲精品第二区| 女人久久www免费人成看片| 国产男女内射视频| 伊人久久国产一区二区| 日本av免费视频播放| 婷婷色综合www| 国产成人一区二区在线| av免费在线看不卡| 午夜精品国产一区二区电影| 久久99精品国语久久久| 国产精品久久久久久精品电影小说| 91精品三级在线观看| 国产精品国产三级国产av玫瑰| 日韩一区二区三区影片| 制服丝袜香蕉在线| 天美传媒精品一区二区| 午夜影院在线不卡| 观看av在线不卡| 精品久久久精品久久久| 午夜福利,免费看| 色吧在线观看| 在线亚洲精品国产二区图片欧美 | 妹子高潮喷水视频| 一级,二级,三级黄色视频| 亚洲成人手机| 国产一区二区三区综合在线观看 | 午夜激情av网站| 看十八女毛片水多多多| av一本久久久久| av在线app专区| 在线观看免费日韩欧美大片 | 欧美日韩成人在线一区二区| 夜夜骑夜夜射夜夜干| 伦精品一区二区三区| xxx大片免费视频| 中文字幕亚洲精品专区| 伊人亚洲综合成人网| 国产成人a∨麻豆精品| 少妇被粗大的猛进出69影院 | 日本猛色少妇xxxxx猛交久久| 久久久久久人妻| 亚洲av国产av综合av卡| av女优亚洲男人天堂| 国产欧美亚洲国产| 人人澡人人妻人| 男人添女人高潮全过程视频| 人人妻人人澡人人看| 秋霞在线观看毛片| av网站免费在线观看视频| 啦啦啦视频在线资源免费观看| 久热这里只有精品99| 亚洲国产av新网站| 亚洲国产欧美日韩在线播放| 免费人妻精品一区二区三区视频| 狂野欧美激情性bbbbbb| 永久免费av网站大全| 精品少妇内射三级| 岛国毛片在线播放| 欧美日韩视频高清一区二区三区二| 精品久久久噜噜| 人人妻人人澡人人看| 麻豆精品久久久久久蜜桃| 狠狠婷婷综合久久久久久88av| 国产黄片视频在线免费观看| 国产毛片在线视频| 久久ye,这里只有精品| tube8黄色片| 少妇丰满av| 久久精品国产亚洲网站| 我的老师免费观看完整版| 热re99久久国产66热| 色5月婷婷丁香| 国产国拍精品亚洲av在线观看| 99久久人妻综合| 国产精品无大码| 丝袜脚勾引网站| 人体艺术视频欧美日本| av卡一久久| 中国美白少妇内射xxxbb| 自拍欧美九色日韩亚洲蝌蚪91| 亚洲美女搞黄在线观看| 街头女战士在线观看网站| 简卡轻食公司| 两个人的视频大全免费| 能在线免费看毛片的网站| 欧美日本中文国产一区发布| 人人妻人人添人人爽欧美一区卜| 免费人成在线观看视频色| 亚洲国产精品专区欧美| 久久久久久人妻| 黄片无遮挡物在线观看| 久久99热6这里只有精品| 成人毛片60女人毛片免费| 久久人人爽人人爽人人片va| videos熟女内射| 日韩伦理黄色片| 丰满饥渴人妻一区二区三| 欧美精品人与动牲交sv欧美| 女性被躁到高潮视频| 久久女婷五月综合色啪小说| 国产精品久久久久久av不卡| 亚洲中文av在线| 国产综合精华液| av视频免费观看在线观看| av免费在线看不卡| 91成人精品电影| 日韩不卡一区二区三区视频在线| 精品99又大又爽又粗少妇毛片| 国产午夜精品久久久久久一区二区三区| 美女国产高潮福利片在线看| 老司机影院毛片| av国产精品久久久久影院| 在线播放无遮挡| 2018国产大陆天天弄谢| 国产淫语在线视频| 九色成人免费人妻av| 亚洲国产毛片av蜜桃av| 爱豆传媒免费全集在线观看| 国产精品麻豆人妻色哟哟久久| 日韩制服骚丝袜av| 亚洲国产精品国产精品| 精品一区二区免费观看| 国产欧美日韩一区二区三区在线 | 涩涩av久久男人的天堂| 日韩制服骚丝袜av| 精品亚洲乱码少妇综合久久| 人人妻人人澡人人看| 飞空精品影院首页| 久久精品国产自在天天线| 免费看av在线观看网站| 日本色播在线视频| 久久久久久久大尺度免费视频| 黄片无遮挡物在线观看| 婷婷色av中文字幕| 男人操女人黄网站| 国产视频内射| 国产精品无大码| 国产乱来视频区| 亚洲精品视频女| 亚洲国产色片| 日韩av不卡免费在线播放| 久久久久精品性色| 久久免费观看电影| 一边摸一边做爽爽视频免费| 国产精品偷伦视频观看了| 免费黄色在线免费观看| 欧美亚洲 丝袜 人妻 在线| 狂野欧美白嫩少妇大欣赏| 中文天堂在线官网| 久久久久国产精品人妻一区二区| 2022亚洲国产成人精品| 青春草国产在线视频| 亚洲激情五月婷婷啪啪| 久久人人爽人人片av| 一级,二级,三级黄色视频| 熟女人妻精品中文字幕| 婷婷色麻豆天堂久久| 九色亚洲精品在线播放| 最新的欧美精品一区二区| 在线免费观看不下载黄p国产| 成人毛片60女人毛片免费| 老司机亚洲免费影院| 你懂的网址亚洲精品在线观看| 国模一区二区三区四区视频| 99国产综合亚洲精品| 一区二区三区免费毛片| 日本免费在线观看一区| 中文乱码字字幕精品一区二区三区| 午夜福利在线观看免费完整高清在| 一本久久精品| 国产免费一级a男人的天堂| 在线 av 中文字幕| 男女啪啪激烈高潮av片| 国产日韩欧美视频二区| 街头女战士在线观看网站| 国产69精品久久久久777片| 国产精品国产三级专区第一集| 国产日韩欧美视频二区| 国产 一区精品| 国产精品久久久久久久久免| 最黄视频免费看| 久久久久久久大尺度免费视频| 精品久久久久久久久亚洲| 18禁动态无遮挡网站| 欧美bdsm另类| 新久久久久国产一级毛片| 成人国产av品久久久| 国产成人91sexporn| 亚洲精品一区蜜桃| 免费不卡的大黄色大毛片视频在线观看| 日本91视频免费播放| 黑人高潮一二区| 久久国产精品男人的天堂亚洲 | 下体分泌物呈黄色| 2022亚洲国产成人精品| 美女视频免费永久观看网站| 精品国产一区二区久久| 国产高清三级在线| 夫妻午夜视频| 高清视频免费观看一区二区| 日日摸夜夜添夜夜爱| 成人亚洲精品一区在线观看| 一本大道久久a久久精品| 久久人妻熟女aⅴ| 日本欧美国产在线视频| 男女边摸边吃奶| 日韩一区二区三区影片| 日韩中字成人| 精品亚洲乱码少妇综合久久| 自拍欧美九色日韩亚洲蝌蚪91| 亚洲丝袜综合中文字幕| 在线观看国产h片| 99国产精品免费福利视频| 一区二区三区四区激情视频| 大陆偷拍与自拍| av不卡在线播放| 人妻夜夜爽99麻豆av| 精品人妻熟女av久视频| 91国产中文字幕| 国产精品蜜桃在线观看| 亚洲av.av天堂| 天天影视国产精品| 狂野欧美激情性xxxx在线观看| 亚洲性久久影院| 国产av国产精品国产| 久久女婷五月综合色啪小说| 欧美 亚洲 国产 日韩一| 欧美精品人与动牲交sv欧美| 啦啦啦啦在线视频资源| 国产伦精品一区二区三区视频9| 日本91视频免费播放| 国产亚洲欧美精品永久| 熟女av电影| 日韩成人av中文字幕在线观看| 精品人妻熟女毛片av久久网站| av在线播放精品| 成年人免费黄色播放视频| 久久久久人妻精品一区果冻| 国产午夜精品一二区理论片| 免费观看性生交大片5| 国产成人一区二区在线| 久久ye,这里只有精品| 日韩欧美一区视频在线观看| 综合色丁香网| 99精国产麻豆久久婷婷| 水蜜桃什么品种好| 日本色播在线视频| 在线观看人妻少妇| 国产片内射在线| 国产在线视频一区二区| 性色avwww在线观看| 永久免费av网站大全| 麻豆精品久久久久久蜜桃| 国产一区二区在线观看日韩| 新久久久久国产一级毛片| 2018国产大陆天天弄谢| 99热这里只有是精品在线观看| av网站免费在线观看视频| 丰满饥渴人妻一区二区三| 99热国产这里只有精品6| 日本91视频免费播放| 色哟哟·www| 亚洲性久久影院| 丝袜美足系列| 交换朋友夫妻互换小说| 欧美亚洲日本最大视频资源| 七月丁香在线播放| 精品人妻在线不人妻| 18禁在线播放成人免费| 亚洲人成77777在线视频| 一本一本综合久久| 大香蕉久久成人网| 国产黄片视频在线免费观看| 免费av不卡在线播放| 老司机亚洲免费影院| 国产精品国产三级专区第一集| 亚洲国产成人一精品久久久| xxx大片免费视频| 亚洲欧美成人精品一区二区| 精品少妇内射三级| 男的添女的下面高潮视频| 婷婷色av中文字幕| 日韩大片免费观看网站| 亚洲精品一二三| 日日爽夜夜爽网站| 三级国产精品欧美在线观看| 热re99久久精品国产66热6| 久久精品人人爽人人爽视色| 亚洲精品日本国产第一区| 国产精品偷伦视频观看了| 乱人伦中国视频| 免费久久久久久久精品成人欧美视频 | 在线观看人妻少妇| 搡老乐熟女国产| 国产精品.久久久| 在线 av 中文字幕| 一区在线观看完整版| 久久久国产欧美日韩av| 在线观看国产h片| 国产成人精品在线电影| 九色亚洲精品在线播放| 久久久久精品久久久久真实原创| 国产淫语在线视频| 亚洲色图综合在线观看| 满18在线观看网站| 亚洲国产欧美日韩在线播放| 大码成人一级视频| 亚洲在久久综合| 免费观看的影片在线观看| 免费高清在线观看视频在线观看| 日日啪夜夜爽| 搡老乐熟女国产| 亚洲人成77777在线视频| 九色亚洲精品在线播放| 最新中文字幕久久久久| 精品一品国产午夜福利视频| 色视频在线一区二区三区| 大陆偷拍与自拍| 亚洲精品成人av观看孕妇| 国产精品秋霞免费鲁丝片| 人妻 亚洲 视频| 一二三四中文在线观看免费高清| 人成视频在线观看免费观看| 三上悠亚av全集在线观看| 2018国产大陆天天弄谢| 国产在线免费精品| 亚洲欧美中文字幕日韩二区| 久久精品久久久久久噜噜老黄| 国产淫语在线视频| 国产成人免费无遮挡视频| 91久久精品电影网| 熟妇人妻不卡中文字幕| 欧美另类一区| 欧美激情极品国产一区二区三区 | 亚洲丝袜综合中文字幕| 国产成人免费无遮挡视频| 伊人亚洲综合成人网| 精品99又大又爽又粗少妇毛片| 午夜久久久在线观看| 久久久久久久久久久免费av| 少妇人妻精品综合一区二区| 菩萨蛮人人尽说江南好唐韦庄| 考比视频在线观看| videossex国产| 免费高清在线观看视频在线观看| 91成人精品电影| 免费大片18禁| 大话2 男鬼变身卡| 中文字幕亚洲精品专区| 国产精品欧美亚洲77777| 成人亚洲精品一区在线观看| 亚洲欧美日韩另类电影网站| 日韩制服骚丝袜av| 熟女av电影| 免费观看的影片在线观看| 亚洲色图 男人天堂 中文字幕 | 亚洲久久久国产精品| av不卡在线播放| 美女主播在线视频| 日韩欧美一区视频在线观看| 好男人视频免费观看在线| 18在线观看网站| 涩涩av久久男人的天堂| 国产成人av激情在线播放 | 美女内射精品一级片tv| 国产精品国产三级专区第一集| 日本91视频免费播放| 天美传媒精品一区二区| 91久久精品电影网| 国产在线一区二区三区精| 亚洲av电影在线观看一区二区三区| 夜夜看夜夜爽夜夜摸| 久久精品久久久久久久性| 亚洲国产欧美在线一区| av有码第一页| 韩国av在线不卡| 中国三级夫妇交换| 国产探花极品一区二区| 亚洲精品日本国产第一区| 又大又黄又爽视频免费| 亚洲精华国产精华液的使用体验| 亚洲精品国产av成人精品| 哪个播放器可以免费观看大片| 精品视频人人做人人爽| 好男人视频免费观看在线| 国产精品成人在线| 国产淫语在线视频| 一区二区三区免费毛片| 亚洲美女黄色视频免费看| 精品视频人人做人人爽| 精品国产国语对白av| 亚洲美女黄色视频免费看| 成年女人在线观看亚洲视频| 国产免费一区二区三区四区乱码| 中文欧美无线码| 一个人免费看片子| 最近中文字幕高清免费大全6| 久久热精品热| 十八禁高潮呻吟视频| 天美传媒精品一区二区| 国产精品 国内视频| 国产亚洲av片在线观看秒播厂| 视频中文字幕在线观看| 久久久久久久久久久久大奶| 国产亚洲精品第一综合不卡 | 久久久久久人妻| 亚洲国产精品一区三区| 国产成人精品无人区| 亚洲av在线观看美女高潮| 亚洲情色 制服丝袜| 欧美精品人与动牲交sv欧美| 丁香六月天网| 亚洲,一卡二卡三卡| 2022亚洲国产成人精品| 国产免费又黄又爽又色|